James R. Turchen

Array ( [id] => 6696410 [patent_doc_number] => 20030108604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Low-substituted hydroxypropyl cellulose and agent serving both as binder and disintegrant for dry direct compression' [patent_app_type] => new [patent_app_number] => 10/315324 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4515 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108604.pdf [firstpage_image] =>[orig_patent_app_number] => 10315324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368850 [patent_doc_number] => 20040006176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Nucleoside analog libraries' [patent_app_type] => new [patent_app_number] => 10/306253 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 16602 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006176.pdf [firstpage_image] =>[orig_patent_app_number] => 10306253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788134 [patent_doc_number] => 20030139373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Method for cancer therapy' [patent_app_type] => new [patent_app_number] => 10/290652 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6451 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139373.pdf [firstpage_image] =>[orig_patent_app_number] => 10290652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6693075 [patent_doc_number] => 20030040507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Pharmaceutical composition comprising ifosfamide and carnitine' [patent_app_type] => new [patent_app_number] => 10/266708 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 660 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040507.pdf [firstpage_image] =>[orig_patent_app_number] => 10266708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683898 [patent_doc_number] => 20030119762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => '5\'-substituted-ribofuranosyl benzimidazoles as antiviral agents' [patent_app_type] => new [patent_app_number] => 10/263889 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18422 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119762.pdf [firstpage_image] =>[orig_patent_app_number] => 10263889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 546021 [patent_doc_number] => 07164014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Protected linker compounds' [patent_app_type] => utility [patent_app_number] => 10/256510 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5627 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/164/07164014.pdf [firstpage_image] =>[orig_patent_app_number] => 10256510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669676 [patent_doc_number] => 20030114660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Preparation of phosphorothioate oligomers' [patent_app_type] => new [patent_app_number] => 10/253981 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25723 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114660.pdf [firstpage_image] =>[orig_patent_app_number] => 10253981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985544 [patent_doc_number] => 06924272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-02 [patent_title] => 'Medicinal composition for diabetic neuropathy' [patent_app_type] => utility [patent_app_number] => 10/381716 [patent_app_country] => US [patent_app_date] => 2002-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4622 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924272.pdf [firstpage_image] =>[orig_patent_app_number] => 10381716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7616992 [patent_doc_number] => 06946449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => 'Partial and full agonists of A1 adenosine receptors' [patent_app_type] => utility [patent_app_number] => 10/194335 [patent_app_country] => US [patent_app_date] => 2002-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17374 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946449.pdf [firstpage_image] =>[orig_patent_app_number] => 10194335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6527437 [patent_doc_number] => 20020192732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Method for quantifying cholesterol in high density lipoprotein' [patent_app_type] => new [patent_app_number] => 10/190793 [patent_app_country] => US [patent_app_date] => 2002-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3810 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192732.pdf [firstpage_image] =>[orig_patent_app_number] => 10190793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999689 [patent_doc_number] => 06911540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-28 [patent_title] => '2′ Modified oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/186058 [patent_app_country] => US [patent_app_date] => 2002-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7641 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911540.pdf [firstpage_image] =>[orig_patent_app_number] => 10186058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6686076 [patent_doc_number] => 20030029799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Carbohydrate purification using ultrafiltration, reverse osmosis and nanofiltration' [patent_app_type] => new [patent_app_number] => 10/184211 [patent_app_country] => US [patent_app_date] => 2002-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14453 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20030029799.pdf [firstpage_image] =>[orig_patent_app_number] => 10184211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716437 [patent_doc_number] => 20030027785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Joint lubrication with P2Y purinergic receptor agonists' [patent_app_type] => new [patent_app_number] => 10/183320 [patent_app_country] => US [patent_app_date] => 2002-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7249 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027785.pdf [firstpage_image] =>[orig_patent_app_number] => 10183320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658617 [patent_doc_number] => 20030078414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Oligonucleotides having alkylphosphonate linkages and methods for their preparation' [patent_app_type] => new [patent_app_number] => 10/163439 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14145 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078414.pdf [firstpage_image] =>[orig_patent_app_number] => 10163439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537768 [patent_doc_number] => 20020193389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Method of inhibiting neoplastic cells with imidazoquinazoline derivatives' [patent_app_type] => new [patent_app_number] => 10/158455 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35015 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193389.pdf [firstpage_image] =>[orig_patent_app_number] => 10158455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1028114 [patent_doc_number] => 06881831 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-19 [patent_title] => 'Nucleic acid-based compounds and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/146175 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3131 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/881/06881831.pdf [firstpage_image] =>[orig_patent_app_number] => 10146175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658618 [patent_doc_number] => 20030078415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Regioselective synthesis of 2\'-O-modified nucleosides' [patent_app_type] => new [patent_app_number] => 10/123597 [patent_app_country] => US [patent_app_date] => 2002-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16663 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078415.pdf [firstpage_image] =>[orig_patent_app_number] => 10123597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6675019 [patent_doc_number] => 20030060622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Process for the preparation of 2\'-halo-beta-L-arabinofuranosyl nucleosides' [patent_app_type] => new [patent_app_number] => 10/112403 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12480 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060622.pdf [firstpage_image] =>[orig_patent_app_number] => 10112403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 971788 [patent_doc_number] => 06936173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Carbohydrate purification using ultrafiltration, reverse osmosis and nanofiltration' [patent_app_type] => utility [patent_app_number] => 10/104609 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14563 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936173.pdf [firstpage_image] =>[orig_patent_app_number] => 10104609 [rel_patent_id] =>[rel_patent_doc_number] =>)